(Q89587078)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

title

The expression of PD-1 ligands and IDO1 by macrophage/microglia in primary central nervous system lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

1 reference

central nervous system lymphoma

1 reference

primary central nervous system lymphoma

inferred from title

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

author name string

Yuko Miyasato

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Yasuo Takashima

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Hiroto Takeya

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Hiromu Yano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Azusa Hayano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Takenobu Nakagawa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Keishi Makino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Motohiro Takeya

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Yoshihiro Komohara

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

publication date

1 January 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

Journal of clinical and experimental hematopathology : JCEH

6 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

page(s)

95-101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

Pediatric primary CNS lymphoma: longterm survival after treatment with radiation monotherapy

6 April 2020

cites work

1 reference

12 December 2020

Management of refractory or relapsed primary central nervous system lymphoma (Review).

1 reference

12 December 2020

M2 macrophage/microglial cells induce activation of Stat3 in primary central nervous system lymphoma

1 reference

12 December 2020

Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).

1 reference

12 December 2020

Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphoma

1 reference

12 December 2020

Clinical significance of CD163⁺ tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma

1 reference

12 December 2020

Clinical significance of macrophage heterogeneity in human malignant tumors

1 reference

12 December 2020

Trial watch: IDO inhibitors in cancer therapy

1 reference

12 December 2020

Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice.

1 reference

12 December 2020

Tumor-Associated Macrophages Associate with Cerebrospinal Fluid Interleukin-10 and Survival in Primary Central Nervous System Lymphoma (PCNSL).

1 reference

12 December 2020

An increase in indoleamine 2,3-dioxygenase-positive cells in the tumor microenvironment predicts favorable prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone

1 reference

12 December 2020

The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients

1 reference

12 December 2020

An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma

1 reference

12 December 2020

Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma

1 reference

12 December 2020

First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies.

1 reference

12 December 2020

Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice

1 reference

12 December 2020

Primary central nervous system lymphoma: essential points in diagnosis and management

1 reference

12 December 2020

The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy.

1 reference

12 December 2020

PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma

1 reference

12 December 2020

Primary central nervous system lymphoma

1 reference

12 December 2020

CD163+CD204+ tumor-associated macrophages contribute to T cell regulation via interleukin-10 and PD-L1 production in oral squamous cell carcinoma

1 reference

12 December 2020

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

1 reference

12 December 2020

Optimum immunohistochemical procedures for analysis of macrophages in human and mouse formalin fixed paraffin-embedded tissue samples.

1 reference

12 December 2020

A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)-only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer

1 reference

12 December 2020

Epacadostat Shows Value in Two SCCHN Trials

1 reference

12 December 2020

Tumor endothelial cells accelerate tumor metastasis

1 reference

12 December 2020

Programmed Cell Death Ligand 1 Expression in Primary Central Nervous System Lymphomas: A Clinicopathological Study.

1 reference

12 December 2020

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.

1 reference

12 December 2020

Immune evasion via PD-1/PD-L1 on NK-cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL.

1 reference

12 December 2020

Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes.

1 reference

12 December 2020

Identifiers

DOI

10.3960/JSLRT.18001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29998979%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

1 reference